Abbott Unit Defeats Inequitable Conduct Claims
A federal judge on Tuesday ruled that heart stent patents held by a division of Abbott Laboratories that were previously found to be infringed by Medtronic Vascular Inc. were not procured...To view the full article, register now.
Already a subscriber? Click here to view full article